🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.380
0.00 (0.00%)
At close: Nov 18, 2026, 4:00 PM EST
1.390
+0.010 (0.72%)
After-hours: Nov 18, 2026, 4:20 PM EST

Inhibikase Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
51.7139.2256.499.177.1940.75
Short-Term Investments
141.6239.5441.054.0915.86-
Cash & Short-Term Investments
193.32178.7697.5413.2523.0540.75
Cash Growth
150.02%83.27%636.06%-42.51%-43.44%192.04%
Receivables
----0.040.11
Prepaid Expenses
1.410.320.830.740.161.5
Other Current Assets
41.030.080.221.120.11
Total Current Assets
198.73180.1198.4514.2124.3742.47
Property, Plant & Equipment
--0.150.30.57-
Other Long-Term Assets
3.021.1----
Total Assets
201.75181.298.614.5124.9442.47

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.951.160.940.651.151.09
Accrued Expenses
12.014.082.682.262.42.72
Short-Term Debt
---0.38--
Current Portion of Long-Term Debt
-----0.25
Current Portion of Leases
--0.110.150.15-
Other Current Liabilities
-3.06----
Total Current Liabilities
12.968.33.733.443.74.05
Long-Term Leases
---0.090.21-
Total Liabilities
12.968.33.733.533.94.05

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.130.070.0100.03
Additional Paid-In Capital
387.88315.43189.2577.8768.868.21
Retained Earnings
-199.12-142.68-94.42-66.9-47.87-29.82
Comprehensive Income & Other
-0.110.02-0.0400.1-
Shareholders' Equity
188.8172.994.8710.9821.0438.42
Total Liabilities & Equity
201.75181.298.614.5124.9442.47

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
--0.110.620.350.25
Net Cash (Debt)
193.32178.7697.4312.6322.740.5
Net Cash Growth
150.02%83.47%671.44%-44.36%-43.95%197.05%
Net Cash Per Share
1.161.824.112.105.3713.35
Filing Date Shares Outstanding
200.84170.4290.016.484.834.2
Total Common Shares Outstanding
200.84170.0889.186.194.24.19
Working Capital
185.78171.8194.7210.7720.6838.42
Book Value Per Share
0.941.021.061.775.009.16
Tangible Book Value
188.8172.994.8710.9821.0438.42
Tangible Book Value Per Share
0.941.021.061.775.009.16
Machinery
--0.10.10.24-
SEC Filings: 10-K · 10-Q